About Us
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Protocol for Determining pKa Using Potentiometric Titration
GUIDELINE
In the potentiometric determination of pKa values, a gradual addition of either acidic or basic solution to an API-containing buffer solution occurs. Weak acids receive an acidic solution, while weak bases require a basic solution. pH measurements with a calibrated pH meter are recorded at each incremental addition until equilibrium is reached, marked by a relatively constant pH, signifying the pKa region.
This systematic process helps researchers pinpoint the inflection point on the titration curve, yielding precise pKa values crucial for understanding API behavior in pharmaceutical applications.
METHODS
- The potentiometer was calibrated using standard aqueous buffers with pH values of 4, 7, and 10. Accurate calibration was achieved for precise pH measurements during titration.
- Dissolve the required quantity of the active pharmaceutical ingredient (API) in the respective surfactant. Dilute the solution to achieve a concentration of at least 10-4 M, ensuring optimum sensitivity in detecting changes in the titration curve.
- Prepare 0.1 M sodium hydroxide solution and 0.1 M hydrochloric acid for titration purposes. Maintain a constant ionic strength in the solution by using 0.15 M potassium chloride solution.
- Throughout the titration, maintain the ionic strength of the solution by using 0.15 M potassium chloride solution.
- Before titration, purge the drug solutions with nitrogen to displace dissolved gases, ensuring a controlled and inert environment during the titration process.
- Place the drug solution in a reaction vessel on a magnetic stirrer. Immerse the pH electrode into the solution. Titrate the solution with 0.1 M sodium hydroxide or hydrochloric acid. Continuously monitor pH changes and record readings at regular intervals. 1) 1mM sample solutions were prepared. 2) For titration, 0.1 M HCl, 0.1 M NaOH, and 0.15 KCl solution was prepared. 3) 20 ml 1mM sample solution was made acidic with 0.1 M HCl pH 1.8-2.0 and titration was carried out by adding 0.1 M NaOH until the pH reached 12-12.5 and stabilized.
- Throughout the titration, maintain the ionic strength of the solution by using 0.15 M potassium chloride solution.
- Perform a minimum of three titrations for each molecule to ensure reliability. Occasionally, conduct five or more separate titrations for robust data. Calculate the average pKa values and standard deviations from the multiple titrations to account for variability.
- Record pH readings when the signal drift is consistently less than 0.01 pH units per minute. This ensures accurate and stable pH measurements during titration.
- Analyze the resulting titration curves for inflection points corresponding to the dissociation of acidic or basic functional groups. Calculate pKa values based on the identified inflection points.
Creative Bioarray Relevant Recommendations
- Creative Bioarray provides Lipophilicity and pKa Assays to help customers accurately evaluate the drug lipophilicity and pKa, allowing customers to gain more insight into the solubility and permeability of drugs. We also offer Aqueous Solubility Assays to help customers accurately evaluate the drug solubility, allowing customers to make early modifications to their drugs to alleviate difficulties in the drug research process and improve their bioavailability.
NOTES
- Choose an appropriate indicator for the titration based on the expected pKa value of the acidic or basic compound being analyzed. The indicator should have a pKa value close to the expected pKa of the analyte to ensure a sharp endpoint and accurate determination.
- Identify the buffer region on the titration curve, which indicates where the pH changes minimally with the addition of titrant. The pKa can be determined from the midpoint of this buffer region.
- Calculate the half-equivalence point volume of titrant, which is where the moles of analyte equal half the moles needed for complete titration. At this point, the pH is equal to the pKa of the weak acid or base.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.